Nagase Viita lanzará el excipiente farmacéutico inyectable «SUCROSE SG» en 2025 ...Middle East

PR Newswire - News
OKAYAMA, Japón, 20 de noviembre de 2024 /PRNewswire/ -- Nagase Viita Co., Ltd., miembro del Grupo NAGASE con sede en Okayama (Japón), se dispone a ampliar la línea de SOLBIOTE (TM), excipientes farmacéuticos a base de sacáridos, con el lanzamiento de SUCROSE SG de alta pureza y baja...

Hence then, the article about nagase viita lanzara el excipiente farmaceutico inyectable sucrose sg en 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nagase Viita lanzará el excipiente farmacéutico inyectable «SUCROSE SG» en 2025 )

Apple Storegoogle play

Last updated :

Also on site :